Ad­vo­ca­cy group and for­mer an­titrust of­fi­cial look to com­ment on Il­lu­mi­na's con­tro­ver­sial Grail merg­er

3 years ago
Deals
Pharma

JA­MA study shows phar­ma com­pa­nies strug­gle to meet postap­proval study dead­lines

3 years ago
FDA+

Three phar­ma lead­ers land on For­tune’s 2022 most pow­er­ful women in busi­ness list

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: Cam­brex, Mil­li­pore­Sig­ma open new Eu­ro­pean fa­cil­i­ties in on­go­ing ex­pan­sion ef­forts

3 years ago
Manufacturing

With FDA de­ci­sion one month away, Proven­tion part­ners with Sanofi on US mar­ket­ing for type 1 di­a­betes drug

3 years ago
Deals
R&D

In add-on to eye dis­ease pipeline, Boehringer pays Sur­rozen to ac­quire rights to Wnt drug

3 years ago
Deals
R&D

As­traZeneca taps two more tar­gets from its AI part­ner, again in CKD and IPF

3 years ago
Deals
R&D

Iron­wood's for­mer pipeline spin­out hits an­oth­er speed bump, lay­ing off 45% and turn­ing to­ward the mi­to­chon­dria

3 years ago
People
R&D

Aldeyra touts first part of PhI­II for rare eye dis­ease but ques­tions re­main as FDA meet­ing ap­proach­es

3 years ago
R&D

Dutch CD­MO In­travacc gets NIH grant of up to $14.6M to make gon­or­rhea vac­cine

3 years ago
Manufacturing

Af­ter pre­sid­ing over stormy years, John McHutchi­son picks his 's­trate­gic part­ner' to run As­sem­bly Bio

3 years ago
People

Armed with $125M, Nest­ed Ther­a­peu­tics de­buts with plan to jump­start next-gen pre­ci­sion on­col­o­gy ef­forts

3 years ago
Financing
Startups

Mer­ck­'s $500M bet on Sin­ga­pore leads to new man­u­fac­tur­ing sites mak­ing Keytru­da, Gar­dasil and fu­ture in­halers

3 years ago
Pharma
Manufacturing

Cal­i­for­nia dream­in': Red Tree VC shop takes Boston fund­s' spin­out ap­proach to West Coast

3 years ago
Financing
Startups

UK en­vi­ron­men­tal ini­tia­tive taps a big name in ad­ver­tis­ing to lead US ef­forts

3 years ago
People

Eli Lil­ly and Te­va pre­pare for court bat­tle over mi­graine med ri­val­ry

3 years ago
Pharma
Law

Af­ter cov­er­age re­stric­tions for Alzheimer's drugs, bi­par­ti­san House bill would force CMS to re­view drugs in­di­vid­u­al­ly

3 years ago
Law

CNS-fo­cused gene ther­a­py biotech forges man­u­fac­tur­ing deal for hear­ing loss drug

3 years ago
Deals
Cell/Gene Tx

Pfiz­er, BioN­Tech part­ner with Mar­vel for Avengers and Covid-fight­ing com­ic book

3 years ago
Pharma
Marketing

Two CRLs lat­er, Illi­nois-based CD­MO hit with FDA warn­ing let­ter over 's­pore-form­ing' bac­te­ria and fun­gi

3 years ago
FDA+
Manufacturing

UC Davis mi­cro­bio­me spin­out re­brands in­fant sup­ple­ment busi­ness with na­ture fo­cus

3 years ago
R&D
Pharma

Fin­ger­paint Group taps for­mer WPP and Mc­Cann Health ex­ec for new com­mer­cial role

3 years ago
Pharma
Marketing

FDA+ roundup: Ad­comm date set for Cy­to­ki­net­ics heart drug; New gener­ic drug guid­ance to re­duce fa­cil­i­ty de­lays

3 years ago
FDA+

FDA re­jects Eiger's emer­gency use re­quest for re­pur­posed Covid-19 treat­ment

3 years ago
FDA+
Coronavirus
First page Previous page 443444445446447448449 Next page Last page
A service from the Financial Times